In its warning letters, the FTC warned that these companies’ products are “not generally recognized as safe and effective” for their claimed uses. These products are considered new drugs. misbranded and approved. The agency also warned that these companies cannot sell these products to consumers. They need to obtain FDA approval.
The FTC demanded that these companies must stop advertising that their products can cure or prevent diabetes unless they have scientific evidence including, “when appropriate, including well-controlled human clinical studies.”
In a statement, FTC Bureau of Consumer Protection Acting Director Samuel Levine said, “Out-of-control insulin prices are driving Americans to turn to questionable products rather than proven treatments. The FTC and FDA are joining forces to call out 10 companies for selling supposed diabetes treatments that don’t appear to be supported by sound science.”
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.